In this week’s View, Dr. Eagle explores familial associations and prevalence of cause-specific mortality for thoracic aortic disease and bicuspid aortic valve disease. He then discusses a patient-level network meta-analyses from COMBINE that compares the use of direct-acting oral anticoagulants versus warfarin across the spectrum of kidney function. Finally, Dr. Eagle looks at biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients, as the field of cardio-oncology continues to evolve and grow.

Twitter Links:

• Dr. Kim Eagle: @keaglemd
• American College of Cardiology: @ACCinTouch

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Prevention, Valvular Heart Disease, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Cardiovascular Care Team, Dyslipidemia

Keywords: Atrial Fibrillation, Heart Failure, Interleukin-6, Myocardial Infarction, Receptors, Chimeric Antigen, Risk Factors, Shock, Cardiogenic, T-Lymphocytes, Troponin, Anticoagulants, Arrhythmias, Cardiac, Creatinine, Embolism, Geriatrics, Warfarin, Aortic Aneurysm, Thoracic, Bicuspid Aortic Valve Disease, Heart Valve Diseases, Risk Assessment, Secondary Prevention, Vascular Diseases, EaglesEyeView

< Back to Listings